Koala Biotech: Subsidiary obtains registration certificates for two respiratory virus nucleic acid test kits.

Shanghai Kehua Bio-engineering Co., Ltd. announced that its controlling subsidiary, Suzhou Tianlong Bio-technology Co., Ltd., recently received two medical device registration certificates issued by the National Medical Products Administration. The certificates are for "Respiratory Syncytial Virus Nucleic Acid Test Kit" and "Respiratory Adenovirus Nucleic Acid Test Kit", both valid from July 17, 2025 to July 16, 2030. These kits are used for qualitative testing of corresponding virus nucleic acids in human throat swab samples outside the body. The announcement stated that the new products will enrich the company's product line and have a positive impact on business development, but the future revenue impact cannot be predicted at this time. Investors are advised to pay attention to risks.